# Adherence to Minimally Invasive Testing

> **NCT02251782** · — · COMPLETED · sponsor: **Epigenomics, Inc** · enrollment: 490 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** Epi proColon Test
- **DEVICE:** Fecal Immunochemical Test (FIT)

## Key facts

- **NCT ID:** NCT02251782
- **Lead sponsor:** Epigenomics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02251782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02251782, "Adherence to Minimally Invasive Testing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02251782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*